In addition, the effect of protein ISGylation on lung cancer is dual; it can not only promote tumorigenesis and development by affecting the YAP-proteasome pathway but also inhibit tumor growth by affecting the ubiquitination and degradation of c-Myc (Table 2). Here, MYC is linked to neoplasm.